US nod for malaria relapse treatment

By Linda A Johnson
Updated July 21 2018 - 12:56pm, first published 12:50pm
GlaxoSmithKline's Krintafel has been approved by US regulators to prevent malaria relapse.
GlaxoSmithKline's Krintafel has been approved by US regulators to prevent malaria relapse.

US regulators have approved a simpler, one-dose treatment to prevent relapses of malaria.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options